Two Sigma Securities’s Coeptis Therapeutics Warrants COEPW Stock Holding History

Two Sigma Securities’s Portfolio COEPW Stock Details COEPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,393	Closed	-$237	–	1824
2026 Q1	$237	Buy	+20,393	New	+$245	﹤0.01%	1590
2025 Q3	–	Sell	-31,836	Closed	-$748	–	1483
2025 Q2	$748	Buy	31,836 +20,300	+176%	+$445	﹤0.01%	1413
2025 Q1	$125	Buy	+11,536	New	+$302	﹤0.01%	1391
2024 Q2	–	Sell	-14,026	Closed	-$358	–	3068
2024 Q1	$358	Sell	14,026 -11,204	-44%	-$459	﹤0.01%	2873
2023 Q4	$782	Buy	+25,230	New	+$992	﹤0.01%	2932

Other funds holding COEPW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return

Two Sigma Securities's COEPW Position: Q2 2026 in Review

Two Sigma Securities sold out of Coeptis Therapeutics Warrants (COEPW) in Q2 2026, closing a stake of 20,393 shares — an estimated $237 sold.

Two Sigma Securities first reported a position in COEPW in Q4 2023 and held it in 5 quarters. The position peaked at $782 in Q4 2023. 3 funds tracked by Wall St. Rank hold COEPW as of Q2 2026.

Two Sigma Securities reported no remaining Coeptis Therapeutics Warrants position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 20,393 Coeptis Therapeutics Warrants shares in Q2 2026, an estimated $237.
Two Sigma Securities first reported a position in Coeptis Therapeutics Warrants in Q4 2023 and held it in 5 quarters.
Two Sigma Securities's Coeptis Therapeutics Warrants position peaked at $782 in Q4 2023.
3 funds tracked by Wall St. Rank held Coeptis Therapeutics Warrants as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.